Skip to content

DR. JOHNNY LAEVEREN

Active Private limited companyfounded 2013active for 13 yearsVeerledorp 34, 2431 LaakdalKBO/BCE: BE 0537.504.912

Lifetime

12 annual accounts with figures on one time axis
peak of €199,896 in 2025
€199,896▲ 1.3%
lowest -€3,076 in 2022
€54,203▼ 16.0%
peak of €248,712 in 2025
€248,712▲ 27.9%
€48,456▲ 18.8%
peak of 1 FTE in 2015
-not published
Board1 name since 2013
1 director
Documentsfilings and deeds
26-08-202626 days late
2025micro format
Equity from €194,509 to €248,712Debts from €40,799 to €48,456

Key points

from the 2025 annual accounts

Equity

€248,712 ▲ 27.9%
€195,0002024€249,0002025

Equity rose in 2025 from €194,509 to €248,712.

Turnover

≈ €360,000 estimated

The micro format states no turnover.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Nine of the last ten came late. The 2022 accounts came in latest, 92 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as DR. JOHNNY LAEVEREN has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for DR. JOHNNY LAEVEREN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 28-08-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0537504912
resigns as manager reappointed as director · “In overeenstemming met de regels van de Code van de Medische Deontologie het uitoefenen van de geneeskunde als…” (deed in Dutch) · Discharge granted to · Gazette deed
First establishment Veerledorp 34, Laakdal
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as manager · published on 28-08-2013 · Gazette deed
All 22 events

Comparable companies

same main activity, similar in size and age
Company
DR. JOHNNY LAEVEREN Laakdal €297,168 €199,896 83.7% -
DR. RAFAEL VERLINDEN Balen €301,130 €175,844 98.9% -
BOUDA MEDIC Rixensart €273,968 €210,287 13.7% -
Dokter Pieter Steeno Putte €351,699 €178,486 5.3% -
VIOLA ADDICARE Zoersel €271,467 €177,720 80.0% -
DCV Consult Zandhoven €234,292 €208,322 31.7% -
DR. MICHELS NELE Rumst €388,256 €180,915 89.4% -

These companies have the same main activity as DR. JOHNNY LAEVEREN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €234,000 and €388,000, founded between 2010 and 2015.

Official details

Source: KBO
Status
Active since 12-08-2013Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.221.309.3042431 Laakdal, since 16-08-2013
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

€297,168▲ 26.3%
Employeeson 31-12-2025
1=
Filing
Filed on 26-08-2026
Financials

Insights on DR. JOHNNY LAEVEREN

DR. JOHNNY LAEVEREN files the micro format. That format states no turnover. The gross margin rose from €126,580 in 2014 to €199,896 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. JOHNNY LAEVEREN

What is the company number of DR. JOHNNY LAEVEREN?
The company number of DR. JOHNNY LAEVEREN is 0537.504.912. The VAT number is the same number with BE in front: BE 0537.504.912.
Where is DR. JOHNNY LAEVEREN based?
The registered office is at Veerledorp 34, 2431 Laakdal.Company details
What does DR. JOHNNY LAEVEREN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. JOHNNY LAEVEREN?
DR. JOHNNY LAEVEREN is a private limited company (BV).
When was DR. JOHNNY LAEVEREN founded?
DR. JOHNNY LAEVEREN was founded on 12-08-2013.
Is DR. JOHNNY LAEVEREN still active?
Yes, DR. JOHNNY LAEVEREN is an active enterprise in the KBO register.
How many employees does DR. JOHNNY LAEVEREN have?
DR. JOHNNY LAEVEREN had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR. JOHNNY LAEVEREN?
The turnover in financial year 2025 is about €360,000. This figure is estimated from the gross margin of €199,896 and 30 comparable companies (NACE 86210). It probably lies between €290,000 and €450,000.
Is DR. JOHNNY LAEVEREN profitable?
In financial year 2025, DR. JOHNNY LAEVEREN made a profit of €54,203.
Where can I find the annual accounts of DR. JOHNNY LAEVEREN?
DR. JOHNNY LAEVEREN filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. JOHNNY LAEVEREN due?
DR. JOHNNY LAEVEREN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.